SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Trends > Financial plays

M&A: BASF extends ProNova offer after only 67% sell; DSM confirms Fortitech buy

By Shane Starling , 19-Dec-2012
Last updated on 20-Dec-2012 at 09:38 GMT2012-12-20T09:38:12Z

BASF extends ProNova offer; DSM confirms Fortitech buy

BASF has extended the bid period for its €650m offer to buy high-dose omega-3 specialist Pronova BioPharma, after only 67.2% of the Norwegian firm’s shareholders  agreed to sell their stakes.

The German giant has notified the Oslo Stock Exchange as required by the Norwegian Securities Trading Act, and given the remaining shareholders until January 18, 2013, to accept its offer of 12.5 Norwegian kronas (€1.69) per share.

It needs 90% of Pronova’s share holdings to complete the transaction, and said it would not extend beyond January 18.

“We thank all Pronova shareholders that have been and will be supportive of our offer,” said Michael Heinz, member of the board of executive directors and nutrition and health division.

“With the chances but also the risks for the business of Pronova in mind, we firmly believe that our offer does provide full and fair value for all shareholders. We will maintain our disciplined financial approach to acquisitions.”

The Pronova board has backed the bid which BASF said it still expects to close in Q1 2013 to add it to recent buys like Cognis (2011) and Equateq (May this year).

DSM closes Fortitech deal

Royal DSM completed its €495 million buy-out of New York-based blend specialist Fortitech, a move designed to strengthen its Human Nutrition and Health division.

“We are expanding our value chain presence and will be able to deliver more value to our customers,” said Leendert Staal, president and CEO of DSM Nutritional Products.

“… Our attention is now fully focused on ensuring a smooth integration of the Fortitech business in a timely and efficient manner, with business continuity and customer satisfaction as key priorities for us while we welcome Fortitech's 520 employees to DSM."

The buy boosts DSM’s range with access to flavours, sweeteners, botanical extracts, caffeine, seasonings, proteins, sweeteners and enzymes, with only vitamins and carotenoids being areas of significant overlap.

DSM Nutrition has spent €2.4bn on acquisitions in the past two years. Other buys include Martek, Ocean Nutrition Canada and Vitatene.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars